drugset / Trial / NCT00714558

Pharmacokinetics of Fentanyl Following Intravenous and Oral Routes of Administration in Healthy Volunteers

NCT00714558

Phase 1 Completed 18 enrolled Alza Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is to compare the pharmacokinetics of fentanyl following i.v. and oral administration in healthy volunteers, and to assess the bioavailability of fentanyl following oral administration. Moreover, safety is assessed.

Timeline

Start
2003-04
Primary completion
Completion
2003-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 300 ug Intravenous
Subject Fentanyl Other / unclassified 1 mg Intravenous
Background Naloxone Small molecule
Background Naltrexone Small molecule 50 mg Oral

Indications

No indication recorded.